CIK 0001130598
- Non-accelerated filer
- Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-06 | TYNDALL CAPITAL PARTNERS L P 10% owner | Sale | −5,015 | $2.78 | $14K | 797,092 |
| 2019-09-05 | TYNDALL CAPITAL PARTNERS L P 10% owner | Sale | −400 | $2.75 | $1K | 802,107 |
| 2019-07-26 | GROOPMAN JEROME Director | Grant or award · Stock Option (right to purchase) | +5,833 | 5,833 | ||
| 2019-07-26 | Hoffman Michael B Director | Grant or award · Stock Option (right to purchase) | +5,833 | 5,833 | ||
| 2019-07-26 | MARINO JAMES J Director | Grant or award · Stock Option (right to purchase) | +5,833 | 5,833 | ||
| 2019-07-26 | MEHTA VIREN Director | Grant or award · Stock Option (right to purchase) | +5,833 | 5,833 | ||
| 2019-07-26 | Reddy E Premkumar Director | Grant or award · Stock Option (right to purchase) | +5,833 | 5,833 | ||
| 2019-07-26 | STOVER JACK E Director | Grant or award · Stock Option (right to purchase) | +5,833 | 5,833 | ||
| 2019-07-10 | TYNDALL CAPITAL PARTNERS L P 10% owner | Sale | −2,742 | $2.81 | $8K | 802,507 |
| 2019-07-09 | TYNDALL CAPITAL PARTNERS L P 10% owner | Sale | −8,185 | $2.84 | $23K | 805,249 |
| 2019-06-27 | TYNDALL CAPITAL PARTNERS L P 10% owner | Sale | −1,458 | $3.45 | $5K | 813,434 |
| 2019-06-25 | TYNDALL CAPITAL PARTNERS L P 10% owner | Sale | −1,380 | $3.40 | $5K | 814,892 |
| 2018-12-12 | Maniar Manoj SVP - Product Development | Grant or award · Stock Option (right to purchase) | +5,000 | 5,000 | ||
| 2018-11-05 | Woodman Richard Charles Chief Medical Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-08-29 | Hoffman Michael B Director | Sale | −29,999.26 | $0.45 | $14K | 5,731,116.74 |
| 2018-08-28 | Hoffman Michael B Director | Sale | −20,000 | $0.44 | $9K | 5,791,116 |
| 2018-08-28 | Hoffman Michael B Director | Sale | −30,000 | $0.46 | $14K | 5,761,116 |
| 2018-08-27 | Hoffman Michael B Director | Sale | −20,000 | $0.45 | $9K | 5,811,116 |
| 2018-07-26 | Hoffman Michael B Director | Grant or award · Stock Option (right to purchase) | +87,500 | 87,500 | ||
| 2018-07-26 | MARINO JAMES J Director | Grant or award · Stock Option (right to purchase) | +87,500 | 87,500 |
Page 14 of 16 · 304 trades